{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T17:09:36Z","timestamp":1776445776625,"version":"3.51.2"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.vaccine.2023.01.054","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T15:32:03Z","timestamp":1696606323000},"page":"S114-S133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"S2","title":["Vaccine value profile for Salmonella enterica serovar Paratyphi A"],"prefix":"10.1016","volume":"41","author":[{"given":"Laura B.","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhana","family":"Khanam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firdausi","family":"Qadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Sikorski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.01.054_b0005","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMra020201","article-title":"Typhoid fever","volume":"347","author":"Parry","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.01.054_b0010","doi-asserted-by":"crossref","first-page":"e1688","DOI":"10.1016\/S2214-109X(21)00370-3","article-title":"Burden of enteric fever at three urban sites in Africa and Asia: a multicentre population-based study","volume":"9","author":"Meiring","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2023.01.054_b0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002925","article-title":"Estimating the burden of paratyphoid a in Asia and Africa","volume":"8","author":"Arndt","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2023.01.054_b0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005964","article-title":"The clinical and microbiological characteristics of enteric fever in Cambodia, 2008\u20132015","volume":"11","author":"Kuijpers","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2023.01.054_b0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006051","article-title":"A 23-year retrospective investigation of Salmonella Typhi and Salmonella Paratyphi isolated in a tertiary Kathmandu hospital","volume":"11","author":"Zellweger","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2023.01.054_b0030","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1016\/j.vaccine.2016.03.106","article-title":"Status of paratyphoid fever vaccine research and development","volume":"34","author":"Martin","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.01.054_b0035","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.110008","article-title":"Combined high-resolution genotyping and geospatial analysis reveals modes of endemic urban typhoid fever transmission","volume":"1","author":"Baker","year":"2011","journal-title":"Open Biol"},{"key":"10.1016\/j.vaccine.2023.01.054_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004346","article-title":"The ecological dynamics of fecal contamination and salmonella typhi and salmonella paratyphi A in municipal kathmandu drinking water","volume":"10","author":"Karkey","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2023.01.054_b0045","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1017\/S0950268810001986","article-title":"An outbreak of Salmonella Paratyphi A in a boarding school: a community-acquired enteric fever and carriage investigation","volume":"138","author":"Yang","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2023.01.054_b0050","article-title":"The microbiological and clinical characteristics of invasive salmonella in gallbladders from cholecystectomy patients in kathmandu","volume":"7","author":"Dongol","year":"2012","journal-title":"Nepal. PloS One"},{"key":"10.1016\/j.vaccine.2023.01.054_b0055","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2164-10-36","article-title":"Pseudogene accumulation in the evolutionary histories of Salmonella enterica serovars Paratyphi A and Typhi","volume":"10","author":"Holt","year":"2009","journal-title":"BMC Genomics"},{"key":"10.1016\/j.vaccine.2023.01.054_b0060","doi-asserted-by":"crossref","first-page":"e0003859","DOI":"10.1371\/journal.pntd.0003859","article-title":"A large-scale community-based outbreak of paratyphoid fever caused by hospital-derived transmission in Southern China","volume":"9","author":"Yan","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2023.01.054_b0065","unstructured":"Ryan ET, Andrews JR, John J. Epidemiology, microbiology, clinical manifestations, and diagnosis of enteric (typhoid and paratyphoid) fever - UpToDate. Uptodate n.d. https:\/\/www.uptodate.com\/contents\/epidemiology-microbiology-clinical-manifestations-and-diagnosis-of-enteric-typhoid-and-paratyphoid-fever?search=treatment-andprevention-of-enteric-typhoid-and-paratyphoidfever&source=search_result&selectedTitle=2\u223c150&usage_type=default&display_rank=2 (accessed January 3, 2022)."},{"key":"10.1016\/j.vaccine.2023.01.054_b0070","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1001\/jama.291.21.2607","article-title":"Risk factors for typhoid and paratyphoid fever in Jakarta, Indonesia","volume":"291","author":"Vollaard","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2023.01.054_b0075","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2471\/BLT.09.069310","article-title":"Trends and disease burden of enteric fever in Guangxi province, China, 1994\u20132004","volume":"88","author":"Dong","year":"2010","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2023.01.054_b0080","doi-asserted-by":"crossref","unstructured":"Karkey A, Thompson CN, Tran Vu Thieu N, Dongol S, Le Thi Phuong T, Voong Vinh P, et al. Differential epidemiology of Salmonella Typhi and Paratyphi A in Kathmandu, Nepal: a matched case control investigation in a highly endemic enteric fever setting. PLoS Negl Trop Dis 2013;7:e2391. https:\/\/doi.org\/10.1371\/journal.pntd.0002391.","DOI":"10.1371\/journal.pntd.0002391"},{"key":"10.1016\/j.vaccine.2023.01.054_b0085","doi-asserted-by":"crossref","first-page":"S188","DOI":"10.1093\/infdis\/jiy522","article-title":"Phase I of the Surveillance for Enteric Fever in Asia Project (SEAP): An Overview and Lessons Learned","volume":"218","author":"Barkume","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.01.054_b0090","doi-asserted-by":"crossref","first-page":"S214","DOI":"10.1093\/cid\/ciaa1308","article-title":"Burden of Culture Confirmed Enteric Fever Cases in Karachi, Pakistan: Surveillance For Enteric Fever in Asia Project (SEAP), 2016\u20132019","volume":"71","author":"Yousafzai","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2023.01.054_b0095","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1093\/cid\/ciy1124","article-title":"Epidemiology of Typhoid and Paratyphoid: Implications for Vaccine Policy","volume":"68","author":"Saha","year":"2019","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2023.01.054_b0100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1473-3099(18)30685-6","article-title":"2017 Typhoid and Paratyphoid Collaborators. The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017","volume":"19","author":"Gbd","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.01.054_b0105","unstructured":"Institute for Health Metrics and Evaluation, University of Washington. GBD Results Tool | GHDx. Glob Health Data Exch 2021. http:\/\/ghdx.healthdata.org\/gbd-results-tool (accessed December 31, 2021)."},{"key":"10.1016\/j.vaccine.2023.01.054_b0110","unstructured":"World Health Organization. WHO meeting report: Expert consultation on nontyphoidal Salmonella and broadly protective Salmonella vaccines, 22nd and 24th September 2021. 2021."},{"key":"10.1016\/j.vaccine.2023.01.054_b0115","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/cid\/cix229","article-title":"An appraisal of the clinical features of pediatric enteric fever: systematic review and meta-analysis of the age-stratified disease occurrence","volume":"64","author":"Britto","year":"2017","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2023.01.054_b0120","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.3201\/eid1111.050168","article-title":"Salmonella paratyphi A rates","volume":"11","author":"Ochiai","year":"2005","journal-title":"Asia. Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2023.01.054_b0125","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.trstmh.2005.12.011","article-title":"Emergence of Salmonella enterica serotype Paratyphi A as a major cause of enteric fever in Kathmandu","volume":"100","author":"Woods","year":"2006","journal-title":"Nepal. Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2023.01.054_b0130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3855\/jidc.223","article-title":"Enteric fever in south China: Guangxi province","volume":"2","author":"Jin","year":"2008","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.vaccine.2023.01.054_b0135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1086\/649541","article-title":"Global trends in typhoid and paratyphoid Fever","volume":"50","author":"Crump","year":"2010","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2023.01.054_b0140","first-page":"20592","article-title":"Increase in Salmonella enterica serovar Paratyphi A infections in Phnom Penh, Cambodia, January 2011 to August 2013","volume":"18","author":"Vlieghe","year":"2013","journal-title":"Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull"},{"key":"10.1016\/j.vaccine.2023.01.054_b0145","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-018-5498-2","article-title":"Estimating the incidence of enteric fever in children in India: a multi-site, active fever surveillance of pediatric cohorts","author":"John","year":"2018","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2023.01.054_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241217","article-title":"Time series analysis of cumulative incidences of typhoid and paratyphoid fevers in China using both Grey and SARIMA models","volume":"15","author":"Gao","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.01.054_b0155","doi-asserted-by":"crossref","unstructured":"Gao Q, Liu Z, Xiang J, Zhang Y, Tong MX, Wang S, et al. Impact of Temperature and Rainfall on Typhoid\/Paratyphoid Fever in Taizhou, China: Effect Estimation and Vulnerable Group Identification. Am J Trop Med Hyg 2021:tpmd201457. https:\/\/doi.org\/10.4269\/ajtmh.20-1457.","DOI":"10.4269\/ajtmh.20-1457"},{"key":"10.1016\/j.vaccine.2023.01.054_b0160","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s12098-007-0141-8","article-title":"Vertical transmission of Salmonella paratyphi A","volume":"74","author":"Raveendran","year":"2007","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.vaccine.2023.01.054_b0165","doi-asserted-by":"crossref","first-page":"S196","DOI":"10.1093\/cid\/ciaa1356","article-title":"Hospitalization of Pediatric Enteric Fever Cases, Dhaka, Bangladesh, 2017\u20132019: Incidence and Risk Factors","volume":"71","author":"Saha","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2023.01.054_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008783","article-title":"Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection model","volume":"14","author":"Gibani","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2023.01.054_b0175","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1128\/IAI.68.3.1529-1534.2000","article-title":"Phase 1 and phase 2 studies of Salmonella enterica serovar paratyphi A O-specific polysaccharide-tetanus toxoid conjugates in adults, teenagers, and 2- to 4-year-old children in Vietnam","volume":"68","author":"Konadu","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2023.01.054_b0180","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/cid\/cix042","article-title":"Evaluation of the Clinical and Microbiological Response to Salmonella Paratyphi A Infection in the First Paratyphoid Human Challenge Model","volume":"64","author":"Dobinson","year":"2017","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2023.01.054_b0185","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.3389\/fmicb.2017.02031","article-title":"Assessment and Translation of the Antibody-in-Lymphocyte Supernatant (ALS) Assay to Improve the Diagnosis of Enteric Fever in Two Controlled Human Infection Models and an Endemic Area of Nepal","volume":"8","author":"Darton","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2023.01.054_b0190","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/ng.3143","article-title":"Variation at HLA-DRB1 is associated with resistance to enteric fever","volume":"46","author":"Dunstan","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2023.01.054_b0195","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/s41590-018-0133-z","article-title":"Clonal analysis of Salmonella-specific effector T cells reveals serovar-specific and cross-reactive T cell responses","volume":"19","author":"Napolitani","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2023.01.054_b0200","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41467-017-02540-x","article-title":"MAIT cell clonal expansion and TCR repertoire shaping in human volunteers challenged with Salmonella Paratyphi A","volume":"9","author":"Howson","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2023.01.054_b0205","article-title":"Host restriction, pathogenesis and chronic carriage of typhoidal Salmonella","author":"Barton","year":"2021014","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2023.01.054_b0210","doi-asserted-by":"crossref","first-page":"e00527","DOI":"10.1128\/mBio.00527-16","article-title":"What\u2019s in a name? Species-wide whole-genome sequencing resolves invasive and noninvasive lineages of salmonella enterica serotype paratyphi B","volume":"7","author":"Connor","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2023.01.054_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009748","article-title":"Genetic diversity of Salmonella Paratyphi A isolated from enteric fever patients in Bangladesh from 2008 to 2018","volume":"15","author":"Rahman","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2023.01.054_b0220","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.01.054_b0225","unstructured":"World Health Organization. Prioritiztaion of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including Tuberculosis. Geneva: 2017."},{"key":"10.1016\/j.vaccine.2023.01.054_b0230","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention (U.S.). Antibiotic resistance threats in the United States, 2019. Centers for Disease Control and Prevention (U.S.); 2019. https:\/\/doi.org\/10.15620\/cdc:82532.","DOI":"10.15620\/cdc:82532"},{"key":"10.1016\/j.vaccine.2023.01.054_b0235","unstructured":"Wellcome Trust, Bill & Melinda Gates Foundation. Meeting report: Non-typhoidal (NTS) CHIM workshop, 27 Januaury 2021. 2021."},{"key":"10.1016\/j.vaccine.2023.01.054_b0240","unstructured":"WHO Country Office for India, Department of Biotechnology, Government of India. Indian Priority Pathogen List. To guide research, discovery and development of new antibiotics in Inda. 2021."},{"key":"10.1016\/j.vaccine.2023.01.054_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-019-1443-1","article-title":"Drug-resistant enteric fever worldwide, 1990 to 2018: a systematic review and meta-analysis","volume":"18","author":"Browne","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2023.01.054_b0250","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.01.054_b0255","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.1093\/cid\/ciaa1323","article-title":"Antimicrobial resistance in typhoidal salmonella: surveillance for enteric fever in Asia Project, 2016\u20132019","volume":"71","author":"Qamar","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2023.01.054_b0260","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1093\/cid\/ciaa366","article-title":"Antimicrobial Resistance in Typhoidal Salmonella: Around the World in 3 Days","volume":"71","author":"Saha","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2023.01.054_b0265","unstructured":"Ryan ET, Andrews JR, John J. Treatment and prevention of enteric (typhoid and paratyphoid) fever - UpToDate. Uptodate n.d. https:\/\/www.uptodate.com\/contents\/treatment-and-prevention-of-enteric-typhoid-and-paratyphoid-fever?search=treatment-andprevention-of-enteric-typhoid-and-paratyphoidfever&source=search_result&selectedTitle=1\u223c150&usage_type=default&display_rank=1 (accessed January 3, 2022)."},{"key":"10.1016\/j.vaccine.2023.01.054_b0270","article-title":"Antibiotic Susceptibility Patterns of Salmonella Typhi and Salmonella Paratyphi in a Tertiary Care Hospital in Islamabad","volume":"12","author":"Umair","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.vaccine.2023.01.054_b0275","first-page":"70","article-title":"Increasingly limited options for the treatment of enteric fever in travellers returning to England, 2014\u20132019: a cross-sectional analytical study","author":"Herdman","year":"2021","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2023.01.054_b0280","doi-asserted-by":"crossref","first-page":"S499","DOI":"10.1093\/cid\/ciz705","article-title":"Spatial and Temporal Patterns of Typhoid and Paratyphoid Fever Outbreaks: A Worldwide Review, 1990\u20132018","volume":"69","author":"Kim","year":"2019","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2023.01.054_b0285","doi-asserted-by":"crossref","first-page":"04031","DOI":"10.7189\/jogh.11.04031","article-title":"A review of toolkits and case definitions for detecting enteric fever outbreaks in Asian and African countries from 1965\u20132019","volume":"11","author":"Khaliq","year":"2021","journal-title":"J Glob Health"},{"key":"10.1016\/j.vaccine.2023.01.054_b0290","doi-asserted-by":"crossref","first-page":"567","DOI":"10.7326\/0003-4819-150-8-200904210-00017","article-title":"Gallbladder carriage of Salmonella paratyphi A may be an important factor in the increasing incidence of this infection in South Asia","volume":"150","author":"Khatri","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2023.01.054_b0295","first-page":"346","article-title":"The global burden of typhoid fever","volume":"82","author":"Crump","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2023.01.054_b0300","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1093\/cid\/ciaa481","article-title":"Methodological Considerations for Cost of Illness Studies of Enteric Fever","volume":"71","author":"Mejia","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2023.01.054_b0305","doi-asserted-by":"crossref","first-page":"S293","DOI":"10.1093\/cid\/ciaa1334","article-title":"Typhoid and Paratyphoid Cost of Illness in Bangladesh: Patient and Health Facility Costs From the Surveillance for Enteric Fever in Asia Project II","volume":"71","author":"Mejia","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2023.01.054_b0310","doi-asserted-by":"crossref","first-page":"S306","DOI":"10.1093\/cid\/ciaa1335","article-title":"Typhoid and Paratyphoid Cost of Illness in Nepal: Patient and Health Facility Costs From the Surveillance for Enteric Fever in Asia Project II","volume":"71","author":"Mejia","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2023.01.054_b0315","doi-asserted-by":"crossref","first-page":"S319","DOI":"10.1093\/cid\/ciaa1336","article-title":"Typhoid and Paratyphoid Cost of Illness in Pakistan: Patient and Health Facility Costs From the Surveillance for Enteric Fever in Asia Project II","volume":"71","author":"Mejia","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2023.01.054_b0320","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1093\/cid\/ciaa513","article-title":"Environmental Surveillance as a Tool for Identifying High-risk Settings for Typhoid Transmission","volume":"71","author":"Andrews","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2023.01.054_b0325","unstructured":"World Health Organization. Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report: 2021 2021. https:\/\/www.who.int\/publications-detail-redirect\/9789240027336 (accessed December 30, 2021)."},{"key":"10.1016\/j.vaccine.2023.01.054_b0330","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/cid\/ciaa487","article-title":"Review of Methods Suitable for Environmental Surveillance of Salmonella Typhi and Paratyphi","volume":"71","author":"Matrajt","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2023.01.054_b0335","doi-asserted-by":"crossref","first-page":"e00060","DOI":"10.1128\/AEM.00060-20","article-title":"Reviving the \u201cMoore Swab\u201d: a Classic Environmental Surveillance Tool Involving Filtration of Flowing Surface Water and Sewage Water To Recover Typhoidal Salmonella Bacteria","volume":"86","author":"Sikorski","year":"2020","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2023.01.054_b0340","article-title":"Development of moore swab and ultrafiltration concentration and detection methods for salmonella typhi and salmonella Paratyphi A in wastewater and application in Kolkata, India and Dhaka","volume":"12","author":"Liu","year":"2021","journal-title":"Bangladesh. Front Microbiol"},{"key":"10.1016\/j.vaccine.2023.01.054_b0345","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4269\/ajtmh.18-0428","article-title":"Evaluating PCR-based detection of salmonella typhi and Paratyphi A in the environment as an enteric fever surveillance tool","volume":"100","author":"Saha","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2023.01.054_b0350","unstructured":"World Health Organization. Fever Diagnostic Technology Landscape. 2018."},{"key":"10.1016\/j.vaccine.2023.01.054_b0355","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1093\/cid\/ciaa503","article-title":"The current status of enteric fever diagnostics and implications for disease control","volume":"71","author":"Baker","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2023.01.054_b0360","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3390\/pathogens10040410","article-title":"Enteric fever diagnosis: current challenges and future directions","volume":"10","author":"Neupane","year":"2021","journal-title":"Pathog Basel Switz"},{"key":"10.1016\/j.vaccine.2023.01.054_b0365","doi-asserted-by":"crossref","first-page":"S255","DOI":"10.1093\/infdis\/jiy471","article-title":"The relationship between blood sample volume and diagnostic sensitivity of blood culture for typhoid and paratyphoid fever: a systematic review and meta-analysis","volume":"218","author":"Antillon","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.01.054_b0370","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0035-9203(87)90056-3","article-title":"Diagnostic value of a single, pre-treatment Widal test in suspected enteric fever cases in the Philippines","volume":"81","author":"Buck","year":"1987","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2023.01.054_b0375","article-title":"Evaluation of a typhoid\/paratyphoid diagnostic assay (TPTest) detecting anti-Salmonella IgA in secretions of peripheral blood lymphocytes in patients in Dhaka","volume":"7","author":"Khanam","year":"2013","journal-title":"Bangladesh. PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2023.01.054_b0380","series-title":"LLC","author":"Defense","year":"2021"},{"key":"10.1016\/j.vaccine.2023.01.054_b0385","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.3389\/fmicb.2017.01794","article-title":"Identification of novel serodiagnostic signatures of typhoid fever using a salmonella proteome array","volume":"8","author":"Darton","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2023.01.054_b0390","doi-asserted-by":"crossref","first-page":"e10431","DOI":"10.15252\/emmm.201910431","article-title":"Diagnostic host gene signature for distinguishing enteric fever from other febrile diseases","volume":"11","author":"Blohmke","year":"2019","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.vaccine.2023.01.054_b0395","first-page":"3","article-title":"Salmonella Typhi and Salmonella Paratyphi A elaborate distinct systemic metabolite signatures during enteric fever","author":"N\u00e4sstr\u00f6m","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.vaccine.2023.01.054_b0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006215","article-title":"Diagnostic metabolite biomarkers of chronic typhoid carriage","volume":"12","author":"N\u00e4sstr\u00f6m","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2023.01.054_b0405","article-title":"Samoa","volume":"No. 16, Part 3","author":"Legislative Assembly of Samoa","year":"2015","journal-title":"Food Act"},{"key":"10.1016\/j.vaccine.2023.01.054_b0410","series-title":"Review of antibacterial Medicines for the Treatment of Enteric Fever","author":"Dolecek","year":"2019"},{"key":"10.1016\/j.vaccine.2023.01.054_b0415","unstructured":"World Health Organization. Framework on value of non-typhoidal Salmonella vaccine against AMR. 2020."},{"key":"10.1016\/j.vaccine.2023.01.054_b0420","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vaccine.2018.04.022","article-title":"Typhoid vaccines: WHO position paper, March 2018 - Recommendations","volume":"37","author":"World Health Organization","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.01.054_b0425","series-title":"The 6th Annual meeting of the WHO Product Development for Vaccines Advisory Committee (PDVAC)","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.vaccine.2023.01.054_b0430","doi-asserted-by":"crossref","unstructured":"Hutubessy RCW, Lauer JA, Giersing BK, Sim SY, Jit M, Kaslow DC, et al. The Full Value of Vaccine Assessments (FVVA): a framework to assess and communicate the value of vaccines for investment and introduction decision making 2021.","DOI":"10.2139\/ssrn.3841999"},{"key":"10.1016\/j.vaccine.2023.01.054_b0435","unstructured":"World Health Organization. PDVAC (virtual) meeting on invasive non-typhoidal Salmonella (iNTS) vaccines 2022. https:\/\/www.who.int\/news-room\/events\/detail\/2022\/02\/07\/default-calendar\/pdvac-(virtual)-meeting-on-invasive-non-typhoidal-salmonella-(ints)-vaccines (accessed May 9, 2022)."},{"key":"10.1016\/j.vaccine.2023.01.054_b0440","unstructured":"World Health Organization. Recommendations to assure the quality, safety and efficacy of typhoid conjugate vaccines. Replacement of Annex 3 of WHO Technical Report Series, No. 987. 2020."},{"key":"10.1016\/j.vaccine.2023.01.054_b0445","series-title":"Boston Consulting Group","author":"Trust","year":"2018"},{"key":"10.1016\/j.vaccine.2023.01.054_b0450","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.trstmh.2004.09.012","article-title":"Identification of typhoid fever and paratyphoid fever cases at presentation in outpatient clinics in Jakarta, Indonesia","volume":"99","author":"Vollaard","year":"2005","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2023.01.054_b0455","doi-asserted-by":"crossref","first-page":"S257","DOI":"10.1093\/cid\/ciaa1297","article-title":"Diagnostic Value of Clinical Features to Distinguish Enteric Fever From Other Febrile Illnesses in Bangladesh, Nepal, and Pakistan","volume":"71","author":"Aiemjoy","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2023.01.054_b0460","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12941-016-0147-z","article-title":"What proportion of Salmonella Typhi cases are detected by blood culture? A systematic literature review","volume":"15","author":"Mogasale","year":"2016","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.vaccine.2023.01.054_b0465","first-page":"437","article-title":"The baseline widal titre among the healthy individuals of the hilly areas in the garhwal region of uttarakhand","volume":"7","author":"Pal","year":"2013","journal-title":"India. J Clin Diagn Res JCDR"},{"key":"10.1016\/j.vaccine.2023.01.054_b0470","article-title":"Development and evaluation of a blood culture PCR assay for rapid detection of salmonella paratyphi A in clinical samples","volume":"11","author":"Zhou","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.01.054_b0475","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1128\/CVI.00115-14","article-title":"Serum bactericidal assays to evaluate typhoidal and nontyphoidal Salmonella vaccines","volume":"21","author":"Boyd","year":"2014","journal-title":"Clin Vaccine Immunol CVI"},{"key":"10.1016\/j.vaccine.2023.01.054_b0480","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jim.2018.06.025","article-title":"Setup of luminescence-based serum bactericidal assay against Salmonella Paratyphi A","volume":"461","author":"Necchi","year":"2018","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2023.01.054_b0485","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/cid\/ciy670","article-title":"The impact of vaccination and prior exposure on stool shedding of salmonella typhi and salmonella Paratyphi in 6 controlled human infection studies","volume":"68","author":"Gibani","year":"2019","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2023.01.054_b0490","article-title":"Evidence considerations for vaccine policy (ECVP)* development: Test case for a bivalent typhoid\/paratyphoid A vaccine","author":"Bentsi-Enchill","year":"2021","journal-title":"VASE virtual symposium."},{"key":"10.1016\/j.vaccine.2023.01.054_b0495","series-title":"If we build it, will they come?","author":"Hausdorff","year":"2021"},{"key":"10.1016\/j.vaccine.2023.01.054_b0500","series-title":"Principles and considerations for adding a vaccine to a national immunization programme: from decision to implementation and monitoring","author":"World Health Organization","year":"2014"},{"key":"10.1016\/j.vaccine.2023.01.054_b0505","unstructured":"Lu Y, Roy E, Zhang F, Hirsch A, MacLennan C, Malley R. MAPS vaccine against Salmonella enterica serovars Typhimurium and Enteritidis. 12th International conference on typhoid and other invasive Salmonelloses. 2021."},{"key":"10.1016\/j.vaccine.2023.01.054_b0510","unstructured":"Wellcome. Modified Outer Membrane Vesicles (mOMV) as safe, effective, low cost, multivalent vaccines against typhoid and paratyphoid fever and invasive non-typhoidal Salmonella infections. Wellcome Trust Innov Awards - Grants Funded 2021. https:\/\/wellcome.org\/grant-funding\/people-and-projects\/grants-awarded\/modified-outer-membrane-vesicles-momv-safe (accessed December 31, 2021)."},{"key":"10.1016\/j.vaccine.2023.01.054_b0515","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.3390\/ijms22063287","article-title":"Engineering a novel bivalent oral vaccine against enteric fever","volume":"22","author":"Soulier","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2023.01.054_b0520","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1093\/cid\/ciaa514","article-title":"Overview of the nontyphoidal and paratyphoidal salmonella vaccine pipeline: current status and future prospects","volume":"71","author":"Baliban","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2023.01.054_b0525","unstructured":"MacLennan C. Typhoid and Combination Salmonella Vaccines Pipeline: Opportunities and Challenges. 12th International conference on typhoid and other invasive Salmonelloses. 2021."},{"key":"10.1016\/j.vaccine.2023.01.054_b0530","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.945235","article-title":"Paratyphoid fever a: infection and prevention","volume":"13","author":"Xie","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2023.01.054_b0535","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ijmm.2015.07.004","article-title":"Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate","volume":"305","author":"Xiong","year":"2015","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.vaccine.2023.01.054_b0540","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41541-017-0037-1","article-title":"Design and production of conjugate vaccines against S. Paratyphi A using an O-linked glycosylation system in vivo","volume":"3","author":"Sun","year":"2018","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2023.01.054_b0545","doi-asserted-by":"crossref","first-page":"e0203631","DOI":"10.1371\/journal.pone.0203631","article-title":"Development of a novel S. Typhi and Paratyphi A outer membrane vesicles based bivalent vaccine against enteric fever","volume":"13","author":"Howlader","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.01.054_b0550","unstructured":"Wellcome. Exploiting genetics, genomics, and immunological responses to construct novel conjugate vaccines against Salmonella Paratyphi A; an emerging global health threat. Wellcome-Grants-Award-1-Oct-2005--30-June-2021---120720210xlsx 2020. https:\/\/view.officeapps.live.com\/op\/view.aspx?src=https%3A%2F%2Fcms.wellcome.org%2Fsites%2Fdefault%2Ffiles%2F2021-09%2FWellcome-grants-awarded-1-October-2005-to-30-June-2021-as-at-12072021_0.xlsx&wdOrigin=BROWSELINK (accessed December 31, 2021)."},{"key":"10.1016\/j.vaccine.2023.01.054_b0555","doi-asserted-by":"crossref","first-page":"e00474","DOI":"10.1128\/mSphere.00474-18","article-title":"Improving our understanding of salmonella enterica serovar paratyphi B through the engineering and testing of a live attenuated vaccine strain","volume":"3","author":"Higginson","year":"2018","journal-title":"MSphere"},{"key":"10.1016\/j.vaccine.2023.01.054_b0560","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/21505594.2018.1559673","article-title":"Attenuated Salmonella Typhimurium expressing Salmonella Paratyphoid A O-antigen induces protective immune responses against two Salmonella strains","volume":"10","author":"Liu","year":"2019","journal-title":"Virulence"},{"key":"10.1016\/j.vaccine.2023.01.054_b0565","first-page":"15953","article-title":"Syntheses of salmonella paratyphi A associated oligosaccharide antigens and development towards anti-paratyphoid fever vaccines","volume":"26","author":"Dhara","year":"2020","journal-title":"Chem Weinh Bergstr Ger"},{"key":"10.1016\/j.vaccine.2023.01.054_b0570","unstructured":"World Health Organization. Paratyphoid fever n.d. https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/diseases\/paratyphoid-fever (accessed May 10, 2022)."},{"key":"10.1016\/j.vaccine.2023.01.054_b0575","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clim.2019.03.003","article-title":"Cell mediated immune responses elicited in volunteers following immunization with candidate live oral Salmonella enterica serovar Paratyphi A attenuated vaccine strain CVD 1902","volume":"201","author":"Wahid","year":"2019","journal-title":"Clin Immunol Orlando Fla"},{"key":"10.1016\/j.vaccine.2023.01.054_b0580","unstructured":"Wellcome. Development and Early Clinical Evaluation of a conjugate vaccine that protects against typhoid fever caused by the Salmonella enterica serovars typhi and paratyphi. Wellcome-Grants-Award-1-Oct-2005--30-June-2021---120720210xlsx 2009. https:\/\/view.officeapps.live.com\/op\/view.aspx?src=https%3A%2F%2Fcms.wellcome.org%2Fsites%2Fdefault%2Ffiles%2F2021-09%2FWellcome-grants-awarded-1-October-2005-to-30-June-2021-as-at-12072021_0.xlsx&wdOrigin=BROWSELINK (accessed December 31, 2021)."},{"key":"10.1016\/j.vaccine.2023.01.054_b0585","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1093\/cid\/ciaa343","article-title":"Typhoid conjugate vaccines and enteric fever control: where to next?","volume":"71","author":"Steele","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2023.01.054_b0590","unstructured":"Wellcome. Development of a S. Paratyphi A \/ S. Typhi bivalent vaccine through proof-of-concept (POC) in animals. Wellcome-Grants-Award-1-Oct-2005--30-June-2021---120720210xlsx 2021. https:\/\/view.officeapps.live.com\/op\/view.aspx?src=https%3A%2F%2Fcms.wellcome.org%2Fsites%2Fdefault%2Ffiles%2F2021-09%2FWellcome-grants-awarded-1-October-2005-to-30-June-2021-as-at-12072021_0.xlsx&wdOrigin=BROWSELINK (accessed December 31, 2021)."},{"key":"10.1016\/j.vaccine.2023.01.054_b0595","doi-asserted-by":"crossref","first-page":"e00699","DOI":"10.1128\/IAI.00699-20","article-title":"Salmonella paratyphi A outer membrane vesicles displaying Vi polysaccharide as a multivalent vaccine against enteric fever","volume":"89","author":"Gasperini","year":"2021","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2023.01.054_b0600","doi-asserted-by":"crossref","first-page":"e016283","DOI":"10.1136\/bmjopen-2017-016283","article-title":"The STRATAA study protocol: a programme to assess the burden of enteric fever in Bangladesh, Malawi and Nepal using prospective population census, passive surveillance, serological studies and healthcare utilisation surveys","volume":"7","author":"Darton","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2023.01.054_b0605","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074097","article-title":"Stochastic simulation of endemic Salmonella enterica serovar Typhi: the importance of long lasting immunity and the carrier state","volume":"8","author":"Saul","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.01.054_b0610","doi-asserted-by":"crossref","first-page":"e2642","DOI":"10.1371\/journal.pntd.0002642","article-title":"Predicting the impact of vaccination on the transmission dynamics of typhoid in South Asia: a mathematical modeling study","volume":"8","author":"Pitzer","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2023.01.054_b0615","doi-asserted-by":"crossref","first-page":"C42","DOI":"10.1016\/j.vaccine.2015.04.013","article-title":"A review of typhoid fever transmission dynamic models and economic evaluations of vaccination","volume":"33","author":"Watson","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.01.054_b0620","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/trstmh\/trv075","article-title":"Typhoid transmission: a historical perspective on mathematical model development","volume":"109","author":"Bakach","year":"2015","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2023.01.054_b0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4236\/oalib.1103493","article-title":"A deterministic mathematical model for direct and indirect transmission dynamics of typhoid fever","volume":"04","author":"Edward","year":"2017","journal-title":"OALib"},{"key":"10.1016\/j.vaccine.2023.01.054_b0630","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/2324518","article-title":"Modelling and optimal control of typhoid fever disease with cost-effective strategies","volume":"2017","author":"Tilahun","year":"2017","journal-title":"Comput Math Methods Med"},{"key":"10.1016\/j.vaccine.2023.01.054_b0635","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S1473-3099(18)30804-1","article-title":"Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study","volume":"19","author":"Bilcke","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.01.054_b0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.rinp.2021.105044","article-title":"Fractional order mathematical modeling of typhoid fever disease","volume":"32","author":"Sinan","year":"2022","journal-title":"Results Phys"},{"key":"10.1016\/j.vaccine.2023.01.054_b0645","unstructured":"Madubueze CE, Gweryina RI, Tijani KA. A dynamic model of typhoid fever with optimal control analysis. Ratio Math 2022;41. https:\/\/doi.org\/10.23755\/rm.v41i0.657."},{"key":"10.1016\/j.vaccine.2023.01.054_b0650","first-page":"304","article-title":"Costs of illness due to typhoid fever in an Indian urban slum community: implications for vaccination policy","volume":"22","author":"Bahl","year":"2004","journal-title":"J Health Popul Nutr"},{"key":"10.1016\/j.vaccine.2023.01.054_b0655","first-page":"311","article-title":"A cost-benefit analysis of typhoid fever immunization programmes in an Indian urban slum community","volume":"22","author":"Poulos","year":"2004","journal-title":"J Health Popul Nutr"},{"key":"10.1016\/j.vaccine.2023.01.054_b0660","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1093\/cid\/ciy1122","article-title":"A review of the economic evidence of typhoid fever and typhoid vaccines","volume":"68","author":"Luthra","year":"2019","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2023.01.054_b0665","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1093\/cid\/ciaa367","volume":"71","author":"Carey","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2023.01.054_b0670","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1093\/cid\/ciaa1296","article-title":"Introducing typhoid conjugate vaccine in South Asia: lessons from the surveillance for enteric fever in Asia Project","volume":"71","author":"Carter","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2023.01.054_b0675","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1093\/cid\/ciaa504","article-title":"Review on the recent advances on typhoid vaccine development and challenges ahead","volume":"71","author":"Syed","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23000853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23000853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:32:13Z","timestamp":1759404733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23000853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":135,"alternative-id":["S0264410X23000853"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.01.054","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine value profile for Salmonella enterica serovar Paratyphi A","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.01.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}